临床试验

Efferon LPS Hemoadsorption in in Patients With Thermal Burns

NCT：NCT07568132 · NOT_YET_RECRUITING

NCT编号NCT07568132

状态NOT_YET_RECRUITING

开始日期2026-05-15

完成时间2028-02-27

简要摘要

The aim of the study is to evaluate the safety and efficacy of multimodal (cytokine and lipopolysaccharide) hemoadsorption using the Efferon® LPS device to reduce the severity of clinical symptoms and to prevent the progression of multiple organ dysfunction or to arrest its development in patients with burn disease with an RFI score ≥71 and ≤181. Patients will be randomized in two groups: control group receiving baseline therapy (including CRRT) and treatment group receiving baseline therapy and Efferon® LPS hemoadsorption in combination with CRRT.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。